The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases
Open accessAbstract
Soft tissue sarcomas (STS) are a heterogeneous group of uncommon tumors that show a broad range of differentiation that may reflect etiologic distinction. Routine tabulations of STS are not morphology‐specific. Further, the lack of inclusion of sarcomas arising in all organs in most standard evaluations underestimates the true rates. We analyzed the 1978–2001 Surveillance, Epidemiology and End Results program incidence rates of STS regardless of primary site, except bones and joints, using the 2002 criteria of the WHO classification. There were 26,758 cases available for analysis. Leiomyosarcomas accounted for 23.9%, malignant fibrous histiocytomas 17.1%, liposarcomas 11.5%, dermatofibrosarcomas 10.5%, rhabdomyosarcomas 4.6% and angiosarcomas 4.1%. Almost half (47.9%) of the sarcomas arose in the soft tissues, 14.0% in the skin and 7.0% in the uterus. Overall, incidence rates were highest among black women (6.26/100,000 woman‐years) and the lowest among white women (4.60/100,000). Age‐adjusted rates increased at 1.2% and 0.8% per year among white males and females, respectively, both trends statistically significant, while rates among blacks declined slightly. About 40% of leiomyosarcomas among women were uterine in origin, with a black/white rate ratio of 1.7. This rate ratio increased to 2.0 when we accounted for the lower prevalence of intact uteri among black compared to white women. Total STS rates rose exponentially with age. Rates for both uterine leiomyosarcoma and dermatofibrosarcoma increased rapidly during the childbearing years, peaking at about age 40 and 50, respectively. Incidence patterns of STS varied markedly by histologic type, supporting the notion that these tumors may be etiologically distinct. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
Pathology and genetics of tumours of soft tissue and bone
Fletcher, C. D. �., Unni, K., & Mertens, F. (2002) · Lund University Publications (Lund University) · Cited by 4,467
Self-citationInternational Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Diagnosis of gastrointestinal stromal tumors: A consensus approach
Fletcher, C. D. M., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., Miettinen, M., O'Leary, T. J., Remotti, H., Rubin, B. P., et al. (2002) · Human Pathology · doi:10.1053/hupa.2002.123545 · Cited by 3,419
Self-citationSEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
International Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
Cancer Epidemiology and Prevention
Breslow, L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550210090050 · Cited by 1,424
Comparative analysis of two rates
Miettinen, O., & Nurminen, M. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040211 · Cited by 1,110
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
Crozat, A., Åman, P., Mandahl, N., & Ron, D. (1993) · Nature · doi:10.1038/363640a0 · Cited by 894
Cormier, J. N., & Pollock, R. E. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.94 · Cited by 835
Cited by
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
Stiller, C. A., Trama, A., Serraino, D., Rossi, S., Navarro, C., Chirlaque, M. D., & Casali, P. G. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.011 · Cited by 683
Ducimetière, F., Lurkin, A., Ranchère-Vince, D., Decouvelaere, A.-V., Péoc'h, M., Istier, L., Chalabreysse, P., Muller, C., Alberti, L., Bringuier, P.-P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020294 · Cited by 554
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
Stiller, C. A., Trama, A., Brewster, D. H., Verne, J., Bouchardy, C., Navarro, C., Chirlaque, M. D., Marcos-Gragera, R., Visser, O., Serraino, D., et al. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.09.009 · Cited by 463
Ferrari, A., Sultan, I., Huang, T. T., Rodriguez‐Galindo, C., Shehadeh, A., Meazza, C., Ness, K. K., Casanova, M., & Spunt, S. L. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23252 · Cited by 376
Cutaneous soft tissue sarcoma incidence patterns in the U.S.: An analysis of 12,114 cases
Rouhani, P., Fletcher, C. D. M., Devesa, S. S., & Toro, J. R. (2008) · Cancer · doi:10.1002/cncr.23571 · Cited by 342
Self-citationLoss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST
Prieto-Granada, C. N., Wiesner, T., Messina, J. L., Jungbluth, A. A., Chi, P., & Antonescu, C. R. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000564 · Cited by 294
Mastrangelo, G., Coindre, J., Ducimetière, F., Dei Tos, A. P., Fadda, E., Blay, J., Buja, A., Fedeli, U., Cegolon, L., Frasson, A., et al. (2012) · Cancer · doi:10.1002/cncr.27555 · Cited by 278
Skubitz, K. M., & D'Adamo, D. R. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1409 · Cited by 277
Occupation and cancer in Britain
Rushton, L., Bagga, S., Bevan, R., Brown, T. P., Cherrie, J. W., Holmes, P., Fortunato, L., Slack, R., Van Tongeren, M., Young, C., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605637 · Cited by 265
Metadata
- Authors
- Toro, J. R., Travis, L. B., Wu, H. J., Zhu, K., Fletcher, C. D. M., & Devesa, S. S.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-10-26
- Volume
- 119
- Issue
- 12
- Pages
- 2922-2930
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2082063053
- Cited by
- 680
- References
- 41
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.